Reliant Donates $150K to Career Gear Houston

Letitia Denham

HOUSTON–(BUSINESS WIRE)–Career Gear Houston received a $150,000 boost today from Reliant to empower disadvantaged men through professional development, support and attire needed to gain meaningful employment. The donation will support the “SkillUp” IT Incubator program, which offers beginner and intermediate instruction to train individuals for employment in the stable and growing field of Information Technology. The Houston chapter of the national nonprofit will use the funds to expand

Read More

First Glance: Boston College Eagles

Letitia Denham

The No. 2 Notre Dame Fighting Irish get back on the road this weekend to take on the Boston College Eagles. We kick off our coverage of Boston College with a first glance look at the Eagles.

Game Date: Saturday, Nov. 14
Start Time: 3:30 PM (Eastern)
Network: ABC
Early Line: Notre Dame -13.5

Now let’s look at Boston College.

SCHEDULE/RESULT (5-3)

at Duke – Won

Read More

New Sur La Table Online Culinary Institute to Convene Industry and Online Education Experts, Delivering World-Class Culinary Offering

Letitia Denham

HERNDON, Va.–(BUSINESS WIRE)–Marquee Brands, global brand owner of Sur La Table — a leader in providing a hands-on culinary cooking experience, together with Rouxbe, the world’s leading online culinary content provider, Chef Scott Conant, a successful restaurateur and television personality, and Strategic Education, Inc. (Strategic Education), a leading online higher education company dedicated to advancing economic mobility for all, today announced the launch of the Sur La Table

Read More

Another Covid-19 breakthrough in inhaled multiple sclerosis drug

Letitia Denham



a person with glasses: MailOnline logo


© Provided by Daily Mail
MailOnline logo

A drug that coronavirus patients inhale slashes their risk of falling seriously ill and speeds up recovery, a major study has revealed in the second Covid breakthrough this week.

Just 13 per cent of hospitalised Covid-19 patients given SNG001 fell ill enough to need intensive care, compared to 22 per cent of those who received a placebo.

Patients treated with the drug were

Read More